Vivos therapeutics inc VVOS.US 總覽分析
VVOS 投資分析
看多重點：
- 價值≥4
- 股利≥2
分析結論
價值面評分低，若以價值投資為目標且有長期投資部位，需要嚴格執行自己的出場計畫來減持部位
VVOS 近期報酬表現
4.67%
Vivos therapeutics inc
4.57%
同產業平均
3.26%
S&P500
與 VVOS 同產業的標的表現
- IRIX Iridex corp價值 3 分趨勢 3 分波段 2 分籌碼 -股利 1 分查看更多
VVOS 公司資訊
Vivos Therapeutics, Inc. is a medical technology company focused on developing and commercializing diagnostic and treatment methods for patients suffering from breathing and sleep issues arising from certain dentofacial abnormalities such as obstructive sleep apnea (OSA) and snoring in adults. The Company calls its solution The Vivos Method. The Vivos Method represents the first clinically effective non-invasive, non-surgical, non-pharmaceutical solution for treating mild to severe OSA. The Vivos Method includes treatment regimens that employ the proprietary Complete Airway Repositioning and/or Expansion (CARE) appliance therapy and other modalities that alter the size, shape and position of the soft tissues that comprise a patient's upper airway and/or palate. It comprises various products and services, including Vivos CARE oral appliance therapy, Vivos oral appliances and therapies outside of CARE system, Vivos AireO2, and Vivos Airway Intelligence Service, and others.